Pittsburgh, PA, United States of America

Zhizhou Yue

USPTO Granted Patents = 2 

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhizhou Yue: Innovator in Allosteric Inhibitors

Introduction

Zhizhou Yue is a notable inventor based in Pittsburgh, PA, with a focus on developing innovative compounds for medical applications. He holds two patents that contribute significantly to the field of biochemistry and pharmacology. His work primarily addresses critical health issues, including cancer and neurodegenerative disorders.

Latest Patents

Zhizhou Yue's latest patents include the development of phenyl indole allosteric inhibitors of p97 ATPase. These inventions are directed towards methods of inhibiting p97 and involve compounds and compositions that are useful in such methods. The diseases and conditions that can be treated with these compounds include, but are not limited to, cancer and neurodegenerative disorders susceptible to treatment by inhibition of p97.

Career Highlights

Throughout his career, Zhizhou Yue has worked with prestigious institutions such as the University of Pittsburgh and the National Institutes of Health, a component of the US Department of Health & Human Services. His contributions to research and development in the field of allosteric inhibitors have been recognized and valued in the scientific community.

Collaborations

Zhizhou Yue has collaborated with esteemed colleagues, including Donna Mary Huryn and Peter Wipf, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Zhizhou Yue's innovative work in the development of allosteric inhibitors showcases his commitment to addressing significant health challenges. His contributions to the field of biochemistry are paving the way for potential treatments for serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…